Enteral Nutrition vs. Standard Care for Stem Cell Transplant Patients

This study is looking at two ways to provide nutrition to patients after a stem cell transplant: enteral nutrition (EN), which is given through a tube into the stomach, and standard care parenteral nutrition (PN), which can be given by mouth or through a vein. The main goal is to see if enteral nutrition is safe and practical for patients. Researchers will also compare how these two nutrition methods affect your overall health, quality of life, and survival. You can join if you are between 2 and 25 years old, or if you are 18 or older and planning to have a stem cell transplant. The study is currently unclear on its recruitment status.

Study design
This is an interventional study with a planned enrollment of 40 participants. It compares two different nutrition methods.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Adverse events will be monitored throughout the study, which is expected to last an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06004063

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~40 participants
Updated 2026-04-02 on ClinicalTrials.gov
What's tested:Enteral nutrition (EN)Standard care parenteral nutrition (PN)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Measured over through study completion; an average of 1 year.
Stem Cell
1 sites across 1 states
Texas1
  • Shehla Razvi, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0through study completion; an average of 1 year.